Fundacion Investigacion Interhospitalaria Cardiovascular Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02243137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

David Vivas

Active Ingredients

Drugs in Phase 4 Trials (2)

clopidogrel (plavix) (1 trial)

ticagrelor (brilinta) (1 trial)

Drugs in Phase 3 Trials (1)

acetylsalicylic acid (aspirin) (2 trials)

Drugs in Phase 1 Trials (1)

prasugrel (effient) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4